Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2007
12/27/2007WO2007149395A2 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer
12/27/2007WO2007149381A2 Compositions comprising a ptp-ase inhibitor and use thereof in treating cancer
12/27/2007WO2007148835A1 Agent for overcoming resistance to anti-cancer agent
12/27/2007WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative
12/27/2007WO2007148697A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor
12/27/2007WO2007148676A1 Therapeutic or prophylactic agent for leukemia
12/27/2007WO2007148631A1 Composition for promoting the production of equol
12/27/2007WO2007148488A1 Peptide for reactivation of inactivated gene
12/27/2007WO2007148158A1 Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation
12/27/2007WO2007148078A1 Use cathelicidin antimicrobial protein (hcap18 ) as anticancer agent
12/27/2007WO2007148070A1 Chemical compounds
12/27/2007WO2007147647A1 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same.
12/27/2007WO2007147646A1 OXO-SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINES, PRODUCTION AND USE THEREOF AS DRUGS
12/27/2007WO2007147644A2 Phosphate diester amides
12/27/2007WO2007147613A2 Combinations comprising staurosprorines
12/27/2007WO2007147578A1 Quinoline derivatives, their preparation, their use, and medicaments comprising them
12/27/2007WO2007147576A1 Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them
12/27/2007WO2007147480A2 Polymorphic forms and process
12/27/2007WO2007147255A1 Synthetic monodisperse hemozoin crystals preparation and uses thereof
12/27/2007WO2007147251A1 Ship 1 modulator compounds
12/27/2007WO2007147217A1 Method of treatment of glioma brain tumour
12/27/2007WO2007127175A3 Pharmaceutical compounds
12/27/2007WO2007125321A3 Purine and deazapurine derivatives as pharmaceutical compounds
12/27/2007WO2007125315A3 Pharmaceutical compounds
12/27/2007WO2007103427A9 Medical use of bilirubin and its structural analogues
12/27/2007WO2007099402A3 New 3’-, 7-substituted indirubins and their applications
12/27/2007WO2007072158A3 Pyrimidine derivatives for the treatment of abnormal cell growth
12/27/2007WO2007008691A3 Use of microchimeric cells in the treatment of malignancy
12/27/2007WO2007003933A3 Combination therapy of cancer with azd2171 and gemcitabine
12/27/2007WO2003066824A3 Albumin-fused kunitz domain peptides
12/27/2007WO2002056823A3 Redox therapy for tumors
12/27/2007US20070299132 Stable Aqueous Formulation of a Platin Derivative
12/27/2007US20070299128 Use of Tryptophan Derivatives for the Specific Cytostatic Treatment of Serotonin-Producing Tumors
12/27/2007US20070299126 Substituted pyrrole-indoles
12/27/2007US20070299103 [1,2,4]Triazolo[4,3-A]Pyridine Derivatives for the Treatment of Hyperproliferative Diseases
12/27/2007US20070299099 Acid Addition Salt of Irinotecan
12/27/2007US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors
12/27/2007US20070299088 Novel Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives
12/27/2007US20070299084 Indole Derivatives Useful for Treating Resistance to Antitumor Agents
12/27/2007US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299066 Novel Pyrimidothienoindazoles
12/27/2007US20070299063 N3 alkylated benzimidazole derivatives as mek inhibitors
12/27/2007US20070299052 Inhibitors of IAP
12/27/2007US20070299047 Combination of Organic Compounds
12/27/2007US20070299042 Use of etodolac to treat hyperplasia
12/27/2007US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
12/27/2007US20070299031 Therapeutic agent for tumor of neural origin
12/27/2007US20070299023 P185Neu-Encoding Dna and Therapeutical Uses Thereof
12/27/2007US20070299022 Antisense Oligonucleotide to Inhibit Melanoma Inhibitory Activity Mia
12/27/2007US20070299020 Methods for treatment of ovarian, colorectal or pancreatic cancer using 4-(aminno)-2(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione
12/27/2007US20070299018 Derivatives of Genkwanin and Sakuranetin, Cosmetic and Therapeutic Use Thereof and Preparation Method of Same
12/27/2007US20070299005 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
12/27/2007US20070298132 Berberine as a selective lung cancer agent
12/27/2007US20070298130 Convolvulus Soldanella Compositions and Methods of Use
12/27/2007US20070298124 ammonium trichloro(dioxyethylene-O,O')tellurate; epilepsy, inflammatory bowel disease, Crohn's disease and ulcerative colits
12/27/2007US20070298123 Anti-angiogenic compositions and methods of use
12/27/2007US20070298093 Synergistic Liposomal Adjuvants
12/27/2007US20070298092 Compositions for Delivery of Drug Combinations
12/27/2007US20070298051 Adjuvants Of Immune Response
12/27/2007US20070298048 Non-viral gene delivery system
12/27/2007US20070298044 Enhancing the efficacy of immunotherapies by supplementing with complement
12/27/2007US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
12/27/2007US20070298035 Recombinant immunoglobulin for targeting, treatment and prevention of cancer, transplant rejection and viral infection
12/27/2007US20070298028 Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3)
12/27/2007US20070298016 Methods For The Generation Of Hepatocyte-Like Cells From Human Blastocyst-Derived Stem (Hbs)
12/27/2007US20070298012 Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules
12/27/2007US20070297983 Inhibition of breast carcinoma stem cell growth and metastasis
12/27/2007US20070297982 Preparation And Composition Of Inter-Alpha Inhibitor Proteins From Human Plasma For Therapeutic Use
12/27/2007US20070297980 Geldanamycin and Derivatives Inhibit Cancer Invasion and Identify Novel Targets
12/27/2007US20070297978 for radiolabeling proteins, peptides and ligands with therapeutic radioisotopes such that these radiolabeled agents may be administered directly to patients without the need for additional purification; for the treatment of cancer; e.g. DTPA OR DOTA -antibody or fragments( Fab or Fv fragments) with Y-90
12/27/2007DE102006029573A1 Neue Quinazoline als Kinase-Inhibitoren New quinazolines as kinase inhibitors
12/27/2007DE102006029447A1 Oxo-substituierte Imidazo[1,2b]pyridazine, deren Herstellung und Verwendung als Arzneimittel Oxo-substituted imidazo [1,2-b] pyridazines, their preparation and use as medicaments
12/27/2007DE102006029445A1 Neue 3-Cyano-chinoline als Kinase-Inhibitoren New 3-cyano-quinolines as kinase inhibitors
12/27/2007DE102006028983A1 Phosphorsäurediesteramide Phosphorsäurediesteramide
12/27/2007CA2661433A1 Phosphate diester amides
12/27/2007CA2659124A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
12/27/2007CA2657213A1 Peptide epoxyketones for proteasome inhibition
12/27/2007CA2656825A1 Method of treatment and agents useful for same
12/27/2007CA2656419A1 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/27/2007CA2656413A1 Oxo-substituted imidazo[1,2b]pyridazines, their preparation and use as pharmaceuticals
12/27/2007CA2656333A1 Ship 1 modulator compounds
12/27/2007CA2656168A1 Methods and compositions for targeting hepsin
12/27/2007CA2656064A1 Polymorphic forms and process
12/27/2007CA2656034A1 Fused [d]pyridazin-7-ones
12/27/2007CA2655895A1 Agent for overcoming resistance to anti-cancer agent
12/27/2007CA2655801A1 Therapeutic or prophylactic agent for leukemia
12/27/2007CA2655789A1 Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation
12/27/2007CA2655724A1 Combinations comprising staurosprorines
12/27/2007CA2655022A1 Use cathelicidin antimicrobial protein (hcap18 ) as anticancer agent
12/27/2007CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/27/2007CA2654237A1 Quinoline derivatives, their preparation, their use, and medicaments comprising them
12/27/2007CA2654234A1 Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them
12/27/2007CA2652633A1 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof
12/27/2007CA2652612A1 Inhibitors of akt (protein kinase b)
12/27/2007CA2652457A1 Use of ppd for the adjuvantation of a nucleic acid vaccine
12/26/2007EP1870466A2 Compositions and methods for therapy and diagnosis of prostate cancer
12/26/2007EP1870414A1 Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency
12/26/2007EP1870410A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/26/2007EP1870404A1 Agent for treatment of hematopoietic tumor
1 ... 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 ... 2211